This role offers an experienced Medical Director the opportunity to lead medical strategy for a complex hematologic malignancy, engaging across the hematology-oncology, dermatology, and dermato-oncology communities while shaping how Sobi supports the CTCL patient and provider community. The Senior Medical Director, Hematology - Lymphoma leads the medical strategy for the Cutaneous T-Cell Lymphoma (CTCL) disease area within Hematology Medical Affairs, driving both brand medical strategy and external engagement with Opinion Leaders, community physicians, medical societies, and top accounts.